A. Geier et al., INDUCTION OF APOPTOSIS IN MDA-231 CELLS BY PROTEIN-SYNTHESIS INHIBITORS IS SUPPRESSED BY MULTIPLE AGENTS, Cancer investigation, 14(5), 1996, pp. 435-444
In the present study we investigated the ability of several diverse ag
ents to inhibit MDA-231 cell death induced by two different protein sy
nthesis inhibitors, cycloheximide (CHX) and ricin. Cell death was eval
uated by several techniques: trypan blue staining, determination of th
e released lactic dehydrogenase, transmission electron microscopy, and
DNA fragmentation. Results from DNA gel electrophoresis and electron
microscopy suggest a mechanism of death by apoptosis which terminates
in necrosis. Approximately 60% of cell death was induced either by a c
ontinuous exposure to 30 mu g/ml CHX for 48 hr or by a 1-hr exposure t
o 250 pg/ml ricin followed by a subsequent incubation of 48 hr in the
absence of the drug. Cell survival, in the protein synthesis-inhibited
cells, was enhanced by the following diverse agents: the growth facto
rs EGF (20 ng/ml) and IGF-1 (20 ng/ml), the protein kinase C activator
12-0-tetradecanoyl-phorbol-13-acetate (5 ng/ml), the protein kinase A
activator 8-bromoadenosine 3':5'-cyclic monophosphate (650 mu g/ml),
the nuclease inhibitor aurintricarboxylic acid (100 mu g/ml), and feta
l bovine serum (5%). The survival agents that stimulated protein synth
esis in the control untreated cells had no effect on the CHX-inhibited
protein synthesis, which indicates that new protein synthesis is not
required for cell survival. The same survival agents attenuated the co
ntinuous decrease in protein synthesis in the ricin-exposed cells; the
refore, the involvement of new protein synthesis in the survival mecha
nism could not be excluded. The protein kinase C inhibitor staurospori
ne blocked, in a dose-dependent manner, the survival effect of 12-0-te
tradecanoyl-phorbol-13-acetate and EGF, but not that of aurintricarbox
yclic acid or fetal bovine serum, in the protein synthesis-inhibited c
ells. These results provide evidence for several distinctive pathways,
the activation of which inhibits MDA-231 cell death induced by protei
n synthesis inhibitors. Some of these pathways involved activation of
protein kinases, probably protein kinase C.